The advantages of a novel CoQ10 delivery system in skin photo-protection

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 57-63

  Yue, Yang ^a   Zhou, Huafeng ^a,b   Liu, Guanlan ^a   Li, Yan ^a   Yan, Zemin ^b   Duan, Mingxing ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Jiangsu Longliqi Bioscience Co Ltd   (China)

Author keywords

Antioxidant; Coenzyme Q10; Nano structured lipid carriers; Skin penetration; Ultraviolet

Indexed keywords

GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; NANOCARRIER; SUPEROXIDE DISMUTASE; UBIDECARENONE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL NUCLEUS; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DERMIS; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG TRANSPORT; EMBRYO; EMULSION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; NONHUMAN; PHOTOAGING; PRIORITY JOURNAL; RAT; SKIN PENETRATION; SKIN PERMEABILITY; SKIN PROTECTION; STRATUM CORNEUM; ULTRAVIOLET A RADIATION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DRUG CARRIERS; FEMALE; FIBROBLASTS; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDES; LIPIDS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; NANOSTRUCTURES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SKIN; SKIN ABSORPTION; SKIN AGING; SOLUBILITY; SUNSCREENING AGENTS; SUPEROXIDE DISMUTASE; SURFACE PROPERTIES; UBIQUINONE; ULTRAVIOLET RAYS;

EID: 77952743822     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.032     Document Type: Article

References (40)

1. Basu-Modak S., Gordon M.J., Dobson L.H., Spencer J.P.E., Rice-Evans C., Tyrrell R.M. Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts. Free Radic. Biol. Med. 2003, 35:910-921.
2. Beck R.C.R., Pohlmann A.R., Hoffmeister C., Gallas M.R., Collnot E., Schaefer U.F., Guterres S.S., Lehr C.M. Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers. Eur. J. Pharm. Biopharm. 2007, 67:18-30.
3. Belardinelli R., Tiano L., Littarru G.P. Oxidative stress, endothelial function and coenzyme Q10. BioFactors 2008, 32:129-133.
4. Beyer R.E. The participation of coenzyme Q in free radical production and antioxidation. Free Radic. Biol. Med. 1990, 8:545-565.
5. Diaz G., Melis M., Batetta B., Angius F., Falchi A.M. Hydrophobic characterization of intracellular lipids in situ by Nile Red red/yellow emission ratio. Micron 2008, 39:819-824.
6. Fetoni A.R., Piacentini R., Fiorita A., Paludetti G., Troiani D. Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res. 2009, 1257:108-116.
7. Fuchs J., Huflejt M.E., Rothfuss L.M., Wilson D.S., Carcamo G., Packer L. Acute effects of near ultraviolet and visible light on the cutaneous antioxidant defense system. Photochem. Photobiol. 1989, 50:739-744.
8. Galán A., Troyano A., Vilaboa N.E., Fernández C., de Blas E., Aller P. Modulation of the stress response during apoptosis and necrosis induction in cadmium-treated U-937 human promonocytic cells. Biochim. Biophys. Acta 2001, 1538:38-46.
9. Han Y., Han Z., Yu G., Wang Y., Cui R., Wang C. Inhibitory effect of polypeptide from Chlamys farreri on ultraviolet A-induced oxidative damage on human skin fibroblasts in vitro. Pharmacol. Res. 2004, 49:265-274.
10. Herrling T., Jung K., Fuchs J. Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim. Acta A: Mol. Biol. Spectrosc. 2006, 63:840-845.
11. Hoeller S., Kählig H., Valenta C. Multinuclear NMR characterisation and dermal delivery of fluorinated drugs in soybean-microemulsion systems. J. Pharm. Sci. 2009, 98:2686-2695.
12. Hughes G.A. Nanostructure-mediated drug delivery. Nanomedicine 2005, 1:22-30.
13. Ichihashi M., Ueda M., Budiyanto A., Bito T., Oka M., Fukunaga M., Tsuru K., Horikawa T. UV-induced skin damage. Toxicology 2003, 189:21-39.
14. James A.M., Smith R.A.J., Murphy M.P. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch. Biochem. Biophys. 2004, 423:47-56.
15. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 1990, 9:515-540.
16. Kalpravidh R.W., Wichit A., Siritanaratkul N., Fucharoen S. Effect of coenzyme Q10 as an antioxidant in beta-thalassemia/Hb E patients. Biofactors 2005, 25:225-234.
17. Kotyla T., Kuo F., Moolchandani V., Wilson T., Nicolosi R. Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int. J. Pharm. 2008, 347:144-148.
18. Kumar A., Kaur H., Devi P., Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol. Ther. 2009, 10.1016/j.pharmthera.2009.07.003.
19. Kuo H., Lee H., Hu C., Shun H., Tseng T. Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol. Appl. Pharmacol. 2006, 210:55-62.
20. Küchler S., Radowski M.R., Blaschke T., Dathe M., Plendl J., Haag R., Schäfer -Korting M., Kramer K.D. Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 2009, 71:243-250.
21. Lacoeuille F., Hindre F., Moal F., Roux J., Passirani C., Couturier O., Cales P., Le Jeune J.J., Lamprecht A., Benoit J.P. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int. J. Pharm. 2007, 344:143-149.
22. Latonen L., Laiho M. Cellular UV damage responses-functions of tumor suppressor p53. Biochim. Biophys. Acta 2005, 1755:71-89.
23. Lippa S., Colacicco L., Bondanini F., Call C., Gozzo M.L., Ciccariello M., Angelitti A.G. Plasma levels of coenzyme Q10, vitamin E and lipids in uremic patients on conservative therapy and hemodialysis treatment: some possible biochemical and clinical implications. Clin. Chim. Acta 2000, 292:81-91.
24. Müller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54:S131-S155.
25. Müller R.H., Petersen R.D., Hommoss A., Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug. Deliv. Rev. 2007, 59:522-530.
26. Ognjanovic B.I., Markovic S.D., Pavlovic S.Z., Zikic R.V., Stajn A.S., Saicic Z.S. Combined effects of coenzyme Q10 and Vitamin E in cadmium induced alterations of antioxidant defense system in the rat heart. Environ. Toxicol. Pharmacol. 2006, 22:219-224.
27. Podda M., Traber M.G., Weber C., Yan L., Packer L. UV-irradiation depletes antioxidants and causes oxidative damage in a model of human skin. Free Radic. Biol. Med. 1998, 24:55-65.
28. Raitakari O.T., McCredie R.J., Witting P., Griffiths K.A., Letters J., Sullivan D., Stocker R., Celermajer D.S. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radic. Biol. Med. 2000, 28:1100-1105.
29. Schrader M., Fahimi H.D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta 2006, 1763:1755-1766.
30. Shah R.B., Zidan A.S., Funck T., Tawakkul M.A., Nguyenpho A., Khan M.A. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int. J. Pharm. 2007, 341:189-194.
31. Sheihet L., Chandra P., Batheja P., Devore D., Kohn J., Michniak B. Tyrosine-derived nanospheres for enhanced topical skin penetration. Int. J. Pharm. 2008, 350:312-319.
32. Shen H., Shi C., Shen Y., Ong C. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic. Biol. Med. 1996, 21:139-146.
33. Shindo Y., Hashimoto T. Ultraviolet B-induced cell death in four cutaneous cell lines exhibiting different enzymatic antioxidant defences: involvement of apoptosis. J. Dermatol. Sci. 1998, 17:140-150.
34. Sinatra S.T. Refractory congestive heart failure successfully managed with high dose coenzyme Q10 administration. Mol. Aspects Med. 1997, 18:299-305.
35. Spernath A., Aserin A., Garti N. Fully dilutable microemulsions embedded with phospholipids and stabilized by short-chain organic acids and polyols. J. Colloid Interface. Sci. 2006, 299:900-909.
36. Tanino Y., Budiyanto A., Ueda M., Nakada A., Nyou W.T., Yanagisawa M., Ichihashi M., Yamamoto Y. Decrease of antioxidants and the formation of oxidized diacylglycerol in mouse skin caused by UV irradiation. J. Dermatol. Sci. 2005, 21-28.
37. Tomasetti M., Littarru G.P., Stocker R., Alleva R. Coenzyme Q10 enrichment decreases oxidative DNA damage in human lymphocytes. Free Radic. Biol. Med. 1999, 27:1027-1032.
38. Witting P.K., Pettersson K., Letters J., Stocker R. Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic. Biol. Med. 2000, 29:295-305.
39. Xie Y., Xu B., Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine 2005, 1:184-190.
40. Zhang J., Wang S. Topical use of Coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect. Int. J. Pharm. 2009, 372:66-75.